Indivior Pharmaceuticals (INDV) Short-term Investments (2022 - 2025)

Indivior Pharmaceuticals' Short-term Investments history runs 4 years deep, the most recent figure standing at $1.0 million for Q1 2025.

• On a quarterly basis, Short-term Investments changed N/A year-over-year to $1.0 million in Q1 2025; TTM through Mar 2025 was $1.0 million, a N/A change from a year earlier, with the FY2024 full-year figure at $1.0 million, down 98.94% from the prior year.
• Short-term Investments steadied at $1.0 million in Q1 2025 per INDV's latest filing, from $1.0 million in the prior quarter.
• Across five years, Short-term Investments topped out at $119.0 million in Q4 2022 and bottomed at $1.0 million in Q4 2024.
• The 4-year median for Short-term Investments is $47.5 million (2023), against an average of $53.8 million.
• Across the five-year window, Short-term Investments fell 21.01% in 2023 and slumped 98.94% in 2024, its largest moves.
• Year by year, Short-term Investments stood at $119.0 million in 2022, then retreated by 21.01% to $94.0 million in 2023, then slumped by 98.94% to $1.0 million in 2024, then changed by 0.0% to $1.0 million in 2025.
• Per Business Quant, the three latest INDV Short-term Investments figures stand at $1.0 million (Q1 2025), $1.0 million (Q4 2024), and $94.0 million (Q4 2023).